Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
arise-2
Press Release
Apr 9, 2018
ReGenTree Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome
Read More
Press Release
Oct 31, 2017
ReGenTree Announces the Results of the ARISE-2 Trial With RGN-259 for the Treatment of Dry Eye: Significant Efficacies Were Confirmed in Both Signs and Symptoms
Read More
First
Prev
1
Next
Last
